Michael J. Prinsen

1.4k total citations · 1 hit paper
10 papers, 911 citations indexed

About

Michael J. Prinsen is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Michael J. Prinsen has authored 10 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Hematology. Recurrent topics in Michael J. Prinsen's work include Virus-based gene therapy research (1 paper), HIV Research and Treatment (1 paper) and Gastroesophageal reflux and treatments (1 paper). Michael J. Prinsen is often cited by papers focused on Virus-based gene therapy research (1 paper), HIV Research and Treatment (1 paper) and Gastroesophageal reflux and treatments (1 paper). Michael J. Prinsen collaborates with scholars based in United States, Sweden and Belgium. Michael J. Prinsen's co-authors include David W. Griggs, Peter Ruminski, Neil C. Henderson, John P. Iredale, Christer Betsholtz, Yoshio Katamura, Antonella Pellicoro, Elisabeth Raschperger, Dean Sheppard and Juan Duque Rodríguez and has published in prestigious journals such as Nature Medicine, Blood and PLoS ONE.

In The Last Decade

Michael J. Prinsen

9 papers receiving 897 citations

Hit Papers

Targeting of αv integrin identifies a core molecular path... 2013 2026 2017 2021 2013 200 400 600

Peers

Michael J. Prinsen
Michael J. Prinsen
Citations per year, relative to Michael J. Prinsen Michael J. Prinsen (= 1×) peers Felice Marinosci

Countries citing papers authored by Michael J. Prinsen

Since Specialization
Citations

This map shows the geographic impact of Michael J. Prinsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Prinsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Prinsen more than expected).

Fields of papers citing papers by Michael J. Prinsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Prinsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Prinsen. The network helps show where Michael J. Prinsen may publish in the future.

Co-authorship network of co-authors of Michael J. Prinsen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Prinsen. A scholar is included among the top collaborators of Michael J. Prinsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Prinsen. Michael J. Prinsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Js, Kim, Jingu Lee, Mohamed A. Ahmed, et al.. (2025). Selective inhibition of ERO1α with M6766, a novel small-molecule inhibitor, prevents arterial thrombosis and ischemic stroke in mice. Molecular Therapy. 33(10). 5177–5191. 1 indexed citations
2.
Huang, Wen-Chi, Michael J. Prinsen, Chandrashekhara Manithody, et al.. (2025). Cutibacterium Adaptation to Life on Humans Provides a Potential C acnes Infection Biomarker. Journal of Investigative Dermatology. 146(1). 198–213.
3.
Cancilla, Daniel, Michael P. Rettig, Darja Karpova, et al.. (2024). Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization. Blood Advances. 8(6). 1379–1383. 7 indexed citations
4.
Basta, Jeannine, Lynn W. Robbins, Lisa Stout, et al.. (2020). Pharmacologic inhibition of RGD‐binding integrins ameliorates fibrosis and improves function following kidney injury. Physiological Reports. 8(7). e14329–e14329. 15 indexed citations
5.
6.
Cancilla, Daniel, Marvin J. Meyers, Michael P. Rettig, et al.. (2019). Targeting CXCR4, VLA4, and CXCR2 for Hematopoietic Stem Cell Mobilization. Blood. 134(Supplement_1). 1916–1916. 1 indexed citations
7.
Griggs, David W., Michael J. Prinsen, Mary Ann Campbell, et al.. (2016). Pharmacologic Comparison of Clinical Neutral Endopeptidase Inhibitors in a Rat Model of Acute Secretory Diarrhea. Journal of Pharmacology and Experimental Therapeutics. 357(2). 423–431. 10 indexed citations
8.
Ulmasov, Barbara, Brent A. Neuschwander‐Tetri, Jinping Lai, et al.. (2016). Inhibitors of Arg-Gly-Asp-Binding Integrins Reduce Development of Pancreatic Fibrosis in Mice. Cellular and Molecular Gastroenterology and Hepatology. 2(4). 499–518. 25 indexed citations
9.
Henderson, Neil C., Thomas D. Arnold, Yoshio Katamura, et al.. (2013). Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nature Medicine. 19(12). 1617–1624. 648 indexed citations breakdown →
10.
Gierse, James K., Atli Thorarensen, Erica L. Bradshaw‐Pierce, et al.. (2010). A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation. Journal of Pharmacology and Experimental Therapeutics. 334(1). 310–317. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026